Boundless Bio BOLD
NASDAQ BOLD
$2.44 +0.01 (+0.41%)
At close: Oct 21, 2026 · 4:00 PM EDT

Boundless Bio (BOLD) EPS (Basic) (2023 - 2026)

Updated

Boundless Bio's EPS (Basic) was -$1.06 in Q2 2026, compared with -$0.70 a year earlier.

Analysis

Boundless Bio (BOLD) EPS (Basic) (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Boundless Bio's EPS (Basic) was -$2.85 through Jun 30, 2026; for FY2025, it was -$2.60.

  • In earlier years, EPS (Basic) was -$3.85 in FY2024 and -$40.65 in FY2023.
  • The Q2 2026 figure marks the lowest quarterly EPS (Basic) since Q1 2024.
  • Per Business Quant data, BOLD's EPS (Basic) in the three quarters before Q2 2026 was -$0.61 (Q1 2026), -$0.58 (Q4 2025) and -$0.62 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.30
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.04
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -0.54
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.68
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.62
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -8.44
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -0.04
10 Boundless Bio 55.45 Mn -17.15 Mn - -1.06
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.06
Mar 31, 2026 -0.61
Dec 31, 2025 -0.58
Sep 30, 2025 -0.62
Jun 30, 2025 -0.70
Mar 31, 2025 -0.71
Dec 31, 2024 -0.97
Sep 30, 2024 -0.74
Jun 30, 2024 -0.77
Mar 31, 2024 -12.27
Dec 31, 2023 -9.99
Sep 30, 2023 -10.71
Jun 30, 2023 -10.28
Mar 31, 2023 -9.91
API Access

Boundless Bio EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=BOLD&period=max&api_key=YOUR_API_KEY